Sign in

CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company

ABEONA THERAPEUTICS INC.

Sign in to watch
Ticker
ABEO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
830221517
Phone
646-813-4701
Business address
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
Former names
PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
  1. 4 Planned sale Director sold 5,176 shares at $5.82 ($30,147)
  2. 4 Open-market sale Director sold 10,738 shares at $5.86 ($62,879)
  3. 4 Open-market sale SVP, Chief Legal Officer sold 17,428 shares at $5.86 ($102,053)
  4. 4 Open-market sale Director sold 13,093 shares at $5.86 ($76,669)
  5. 4 Grant or award Chief Financial Officer acquired 13,333 shares (grant or award)
  6. 4 Open-market sale Chief Financial Officer sold 17,795 shares at $6.76 ($120,294)
  7. 4 Open-market sale Chief Executive Officer sold 50,676 shares at $6.76 ($342,570)
  8. 4 Open-market sale SVP, General Counsel sold 10,470 shares at $6.76 ($70,777)
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 885 shares (to pay taxes)
  10. 4 Open-market sale Director sold 2,000 shares at $6.38 ($12,760)
  11. 4 Open-market sale Director sold 8,000 shares at $5.68 ($45,440)
  12. 4 Planned sale Chief Executive Officer sold 25,000 shares at $4.78 ($119,500)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 685 shares (to pay taxes)
  14. 4 Shares withheld for taxes SVP, General Counsel gave up 181 shares (to pay taxes)
  15. 4 Grant or award Director acquired 36,101 shares (grant or award)
  16. 4 Grant or award Director acquired 36,101 shares (grant or award)
  17. 4 Grant or award Director acquired 36,101 shares (grant or award)
  18. 4 Grant or award Director acquired 36,101 shares (grant or award)
  19. 4 Grant or award Director acquired 36,101 shares (grant or award)
  20. 4 Grant or award Director acquired 36,101 shares (grant or award)

Page 4 of 20 · 393 filings